These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]
6. miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. Grignol V; Fairchild ET; Zimmerer JM; Lesinski GB; Walker MJ; Magro CM; Kacher JE; Karpa VI; Clark J; Nuovo G; Lehman A; Volinia S; Agnese DM; Croce CM; Carson WE Br J Cancer; 2011 Sep; 105(7):1023-9. PubMed ID: 21863027 [TBL] [Abstract][Full Text] [Related]
8. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235 [TBL] [Abstract][Full Text] [Related]
9. [Spitz nevus vs 'spitzoid' malignant melanoma. A diagnostic dilemma?]. Rütten A Pathologe; 2007 Nov; 28(6):422-9. PubMed ID: 17846775 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging. Pilch H; Günzel S; Schäffer U; Tanner B; Heine M Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619 [TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)]. de la Fouchardière A; Vergier B Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446 [No Abstract] [Full Text] [Related]
12. [Melanocytic tumours and genetics: new findings]. Dereure O Ann Dermatol Venereol; 2012 Mar; 139(3):243-4. PubMed ID: 22401696 [No Abstract] [Full Text] [Related]
13. Three dermoscopic signs of growth of pigmented lesions. Woltsche N; Piana S; Ferrara G; Hofmann-Wellenhof R; Zalaudek I J Am Acad Dermatol; 2015 Oct; 73(4):e133-5. PubMed ID: 26369851 [No Abstract] [Full Text] [Related]
14. In vivo detection of peripheral clefting in melanocytic lesions. Benati E; Zalaudek I; Piana S; Argenziano G; Moscarella E; Lallas A; Pellacani G; Longo C Br J Dermatol; 2015 Dec; 173(6):1525-6. PubMed ID: 26104850 [No Abstract] [Full Text] [Related]
15. Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas. Guttman-Yassky E; Bergman R; Manov L; Sprecher E; Shaefer Y; Kerner H J Cutan Pathol; 2002 Jul; 29(6):341-6. PubMed ID: 12135464 [TBL] [Abstract][Full Text] [Related]
16. [Step-wise expression of melanoma-associated antigens in tumor progression]. Lehmann JM; Holzmann B; Rothbächer U; Riethmüller G; Johnson JP Onkologie; 1989 Dec; 12(6):273-6. PubMed ID: 2696911 [TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus. Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623 [No Abstract] [Full Text] [Related]
18. Distinguishing Spitz tumors from malignant melanoma: potential role of comparative genomic hybridization and fluorescence in situ hybridization in diagnosis and prognosis. Llewellyn K; Barnhill RL Adv Anat Pathol; 2001 Sep; 8(5):249-54. PubMed ID: 11556532 [No Abstract] [Full Text] [Related]
19. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics. Barnhill RL Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557 [TBL] [Abstract][Full Text] [Related]
20. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Li LX; Crotty KA; McCarthy SW; Palmer AA; Kril JJ Am J Dermatopathol; 2000 Dec; 22(6):489-95. PubMed ID: 11190439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]